Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Hoffjan, J. Epplen (2005)
The genetics of atopic dermatitis: recent findings and future optionsJournal of Molecular Medicine, 83
Asher Asher, Anderson Anderson, Stewart Stewart (1998)
Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)Eur Respir J, 12
R. Sporik, S Holgate, J. Cogswell (1991)
Natural history of asthma in childhood--a birth cohort study.Archives of Disease in Childhood, 66
M. Isidoro-García, I. Dávila, E. Moreno, F. Lorente, R. González-Sarmiento (2005)
Analysis of the leukotriene C4 synthase A-444C promoter polymorphism in a Spanish population.The Journal of allergy and clinical immunology, 115 1
K. Øymar, L. Aksnes (2005)
Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndromeAllergy, 60
M. Isidoro-García, I. Dávila, E. Laffond, E. Moreno, F. Lorente, R. González-Sarmiento (2005)
Interleukin-4 (IL4) and Interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control studyClinical and molecular allergy : CMA, 3
B. Knorr, Luis Franchi, Hans Bisgaard, Jan Vermeulen, Peter Lesouef, N. Santanello, T. Michele, Theodore Reiss, Ha Nguyen, Donna Bratton (2001)
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.Pediatrics, 108 3
D. Vieluf, H. Korting, B. Belohradsky (1989)
Eczematous skin lesions in X-linked immunodeficiency with hyper-IgM.Current problems in dermatology, 18
M. Thompson, K. Gravesande, H. Galczenski, W. Burnham, K. Siminovitch, N. Zamel, Arthur Slutsky, J. Drazen, S. George, Jilly Evans, B. O'dowd (2003)
A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha.Pharmacogenetics, 13 10
H. Fukai, Yoshino Ogasawara, O. Migita, M. Koga, K. Ichikawa, M. Shibasaki, T. Arinami, E. Noguchi (2004)
Association between a polymorphism in cysteinyl leukotriene receptor 2 on chromosome 13q14 and atopic asthma.Pharmacogenetics, 14 10
Malmstrom Malmstrom, Rodriguez‐Gomez Rodriguez‐Gomez, Guerra Guerra (1999)
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study GroupAnn Intern Med, 130
Daniel Straub, Alexander Moeller, S. Minocchieri, Juerg Hamacher, F. Sennhauser, Graham Hall, Johannes Wildhaber (2005)
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthmaEuropean Respiratory Journal, 25
K. Lynch, G. O'neill, Qingyun Liu, D. Im, N. Sawyer, K. Metters, N. Coulombe, M. Abramovitz, D. Figueroa, Z. Zeng, Brett Connolly, Chang Bai, Christopher Austin, A. Châteauneuf, R. Stocco, G. Greig, S. Kargman, S. Hooks, Elizabeth Hosfield, David Williams, A. Ford-hutchinson, C. Caskey, Jilly Evans (1999)
Characterization of the human cysteinyl leukotriene CysLT1 receptorNature, 399
Bjornson Cl, I. Mitchell (2000)
Gender differences in asthma in childhood and adolescence.The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia, 3 8
Yi Shi, D. Yang, Jie Xiong, J. Jia, Bing Huang, You-xin Jin (2005)
Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAsCell Research, 15
G. Capella, E. Grigerio, G. Altomare (2001)
A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.European journal of dermatology : EJD, 11 3
A. Sampson, Salman Siddiqui, D. Buchanan, P. Howarth, S. Holgate, J. Holloway, I. Sayers (2000)
Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukastThorax, 55
H. Williams, C. Robertson, A. Stewart, N. Aït-Khaled, G. Anabwani, R. Anderson, I. Asher, R. Beasley, B. Björkstén, M. Burr, T. Clayton, Julian Crane, P. Ellwood, U. Keil, C. Lai, J. Mallol, F. Martinez, E. Mitchell, S. Montefort, N. Pearce, J. Shah, B. Sibbald, D. Strachan, E. Mutius, S. Weiland (1999)
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.The Journal of allergy and clinical immunology, 103 1 Pt 1
M. Bradley, C. Söderhäll, C. Wahlgren, H. Luthman, M. Nordenskjöld, I. Kockum (2001)
The Wiskott-Aldrich syndrome gene as a candidate gene for atopic dermatitis.Acta dermato-venereologica, 81 5
Shah Aa (1994)
International Study of Asthma and Allergies in Childhood (ISAAC)The Journal of the Association of Physicians of India, 42 3
K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villarán, Andres Pieiro, Lynn Wei, B. Seidenberg, T. Reiss (1999)
Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 130
Jeong-Hee Choi, Hae‐Sim Park, H. Oh, J. Lee, Y. Suh, Choon-Sik Park, H. Shin (2004)
Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenaseHuman Genetics, 114
S. Holgate, M. Peters-Golden, R. Panettieri, W. Henderson (2003)
Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.The Journal of allergy and clinical immunology, 111 1 Suppl
T. Howard, D. Meyers, E. Bleecker (2003)
Mapping susceptibility genes for allergic diseases.Chest, 123 3 Suppl
R. Luoma, A. Koivikko, Markku Viander (1983)
Development of Asthma, Allergic Rhinitis and Atopic Dermatitis by the Age of Five Years: A Prospective Study of 543 NewbornsAllergy, 38
N. Veien, M. Busch-Sørensen, B. Stausbøl‐Grøn (2005)
Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.Journal of the American Academy of Dermatology, 53 1
D. Kaminsky, C. Irvin, H. Moriya, M. Lynn, S. Lang, J. Bates (2003)
Peripheral lung responsiveness assessed by forced oscillations through the wedged bronchoscope.Chest, 123 3 Suppl
Donald Woodmansee, R. Simon (1999)
A pilot study examining the role of zileuton in atopic dermatitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 83 6 Pt 1
J. Carucci, Kenneth Washenik, Alan Weinstein, J. Shupack, David Cohen (1998)
The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.Archives of dermatology, 134 7
T. Ruzicka, J. Ring (1987)
Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema.Acta dermato-venereologica, 67 6
Marek Sanak, M. Pierzchalska, S. Bazan-Socha, Andrzej Szczeklik (2000)
Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma.American journal of respiratory cell and molecular biology, 23 3
D. Leung (2000)
Atopic dermatitis: new insights and opportunities for therapeutic intervention.The Journal of allergy and clinical immunology, 105 5
Yong Yong, Lin He (2005)
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 15
David Yanase, K. David-Bajar (2001)
The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.Journal of the American Academy of Dermatology, 44 1
Asthma and atopic dermatitis share several common features and Cysteinyl‐leukotrienes are mediators that participate in the pathogenesis of both diseases. Recently, a new polymorphism (927T>C) has been identified in cysteinyl‐leukotriene type‐1 receptor (CYSLTR1) gene. This gene is found on the X chromosome. The aim of this study was to analyze this SNP in a population of children with asthma and atopic dermatitis. In this study, 166 individuals, 79 adult controls (CTR) and 87 children with asthma (AA) were included. Forty‐one patients with asthma presented atopic dermatitis (AA‐AD). Adults were chosen as controls to confirm lack of development of asthma and allergy during childhood. Standardized history, physical examination, skin prick tests, and lung function measurements were performed in all patients. The 927T>C CYSLTR1 SNP was analyzed by direct sequencing after PCR amplification. In males (53 individuals), the C allele was significantly more common among AA‐AD patients (47%) than in CTR (8%) (Fisher's p < 0.005; Monte Carlo p < 0.008; OR:9.78; 95%CI: 1.73–55.30). When comparing AA‐AD vs. AA‐NAD (patients with asthma but not atopic dermatitis), significant differences were observed, (47% vs. 15%, Fisher's p = 0.014; Monte Carlo p = 0.022; OR: 4.97; 95%CI: 1.29–19.13). No differences in allele distribution were observed between these disease sub‐groups in females. The 927T>C is a silent SNP; however, it could affect transcription or translation or may be linked to an unidentified, functional polymorphism and thus may pre‐dispose male children to asthma and atopic dermatitis in our population. Further studies are needed to confirm these findings.
Pediatric Allergy and Immunology – Wiley
Published: Aug 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.